# Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

> **NCT02806804** · PHASE3 · UNKNOWN · sponsor: **Beijing Chaoyang District Centre for Disease Control and Prevention** · enrollment: 2400 (estimated)

## Conditions studied

- Quadrivalent Influenza Virus Vaccine

## Interventions

- **BIOLOGICAL:** one dose test vaccine
- **BIOLOGICAL:** one dose commercially available trivalent influenza vaccine
- **BIOLOGICAL:** One dose of Quadrivalent Influenza Virus Vaccine

## Key facts

- **NCT ID:** NCT02806804
- **Lead sponsor:** Beijing Chaoyang District Centre for Disease Control and Prevention
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2016-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806804, "Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02806804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*